Academia Sinica yesterday said that its researchers have developed an antibody testing method for COVID-19 and have made progress synthesizing remdesivir, a medicine that many believe could cure the infection.
The Centers for Disease Control on Tuesday sent serum samples to Academia Sinica of three people who had contact with Taiwan’s first COVID-19 fatality, as part of an effort to determine the source of that infection.
The three had tested negative for RNA viruses, but the centers hoped to discover if they had developed antibodies.
Photo courtesy of Academia Sinica
Test results showed that only one sample had antibodies for COVID-19 and SARS, Academia Sinica Institute of Biomedical Sciences research fellow Lin Yi-ling (林宜玲) said.
The sample was obtained from a Taiwanese businessperson who was not listed as a confirmed case, because their immune system beat the virus, she said.
Little is known about COVID-19, so it is still a mystery whether a person who has recovered from it can contract it again, she added.
The method is useful in tracing the transmission chain of a certain case, Institute of Plant and Microbial Biology Director Wu Shu-hsing (吳素幸) said, but added that testing for RNA viruses tells whether a person contracts COVID-19.
Using molecular biology and genetic engineering, Wu said that she pieced together plasmids — a kind of DNA for expressing antigens — in small templates to make up longer series of plasmids for producing the antigens used to test for COVID-19, SARS and Middle East respiratory syndrome antibodies.
Ordering massive plasmid series from overseas manufacturers takes two to three weeks, Lin said, praising Wu’s team for only needing a week.
After Institute of Biological Chemistry associate research fellow Ho Meng-chiao (何孟樵) purified the nucleocapsid protein of COVID-19 for making reagents, Lin used the western blot method to place the antigens in a serum sample for testing antibody reactions, she said.
Another team led by Institute of Chemistry associate research fellow Chein Rong-jie (陳榮傑) succeeded in synthesizing 100mg of remdesivir in two weeks.
Unable to obtain the raw materials in time, they used materials on hand and molecule synthesis, referencing public-domain literature, to make the drug, which on Thursday was 97 percent as pure as the original, Chein said.
Before the centers tasked them with the mission, Academia Sinica President James Liao (廖俊智) last month formed a task force to speed up the development of antigens, antibodies, drugs and vaccines for COVID-19.
The synthesized drug cannot be used without the consent of the US pharmaceutical firm that manufactures remdesivir, Liao said.
Nonetheless, the achievement showed that Academia Sinica is capable of drug synthesis and could facilitate mass production of the drug after a technology transfer has been completed, he added.
‘DEMOCRATIC FISH’: Soichiro Hayashi said he wants to return Taiwan’s kindness after it helped with relief efforts after the March 11, 2011, earthquake and tsunami Japanese fish farmers are ready to help Taiwan after China banned Taiwanese grouper imports, the Sankei Shimbun reported yesterday. The Chinese General Administration of Customs suspended imports of the fish on Monday last week, citing prohibited chemicals and excessive levels of oxytetracycline allegedly found in grouper imports since December last year. Soichiro Hayashi, president of the Hayashi Trout Farm in Japan’s Fukushima Prefecture, is leading the push for Taiwanese grouper imports, the newspaper said. His call has caught the attention of several large sushi chains, the report said. Hayashi, who is the Fukushima branch head of the Friends of Lee Teng-hui Association in Japan,
‘TROJAN HORSE’ SCHEME: The comment that a bridge would allow China’s PLA to easily launch an attack shows ‘a lack of backbone,’ Taipei Mayor Ko Wen-je said Critics accused Taipei Mayor Ko Wen-je (柯文哲) of being oblivious to national security concerns after he proposed constructing a bridge to link Kinmen and China’s Xiamen (廈門). Ko, who is also the Taiwan People’s Party (TPP) chairman, made the proposal when presiding over the opening ceremony of the party’s office in Kinmen on Saturday. He said the bridge could solve Kinmen’s population, electricity and garbage problems, as well as serve as a shortcut for leaving or entering Taiwan without traveling via Taipei International Airport (Songshan airport). He also proposed building a hospital in Kinmen to attract people who are seeking medical treatment in
OVER THE HUMP: In a seven-day period ending on Wednesday, the nation reported 366,628 new cases, down 19 percent from the 451,358 reported in the previous week The nation might further open up to more arrivals in the next two months, the Central Epidemic Command Center (CECC) said yesterday, as it reported 48,283 new local COVID-19 cases, down from more than 50,000 in the previous few days. Taiwan on Wednesday last week introduced a plan to allow up to 25,000 arrivals per week as part of efforts to gradually reopen borders, which includes reducing mandatory quarantines for inbound travelers from seven to three days, followed by four days in “self-initiated epidemic prevention.” The quota covers inbound Taiwanese arrivals, businesspeople and migrant workers. Former vice president Chen Chien-jen (陳建仁) yesterday said
CECC UPDATE: Officials said the definition of a confirmed COVID-19 case has been revised to include those who are positive in a PCR home test confirmed by a doctor The Central Epidemic Command Center (CECC) yesterday said that it would probably list monkeypox as a category 2 notifiable communicable disease today or tomorrow. The WHO is to convene an emergency committee meeting today in accordance with the International Health Regulations to discuss whether the spread of monkeypox to 39 countries, including 32 non-endemic countries, constitutes a public health emergency of international concern. On Tuesday, the Singaporean Ministry of Health confirmed its first imported case of monkeypox, which is also the first case reported in Southeast Asia. South Korea yesterday reported its first confirmed case of monkeypox — a South Korean national who